Terumo EPS - Earnings per Share 2012-2024 | TRUMY

Terumo earnings per share (EPS) for the twelve months ending June 30, 2024 was $0.37, a 25.95% decline year-over-year.

  • Terumo EPS for the quarter ending June 30, 2024 was $0.15, a 13.1% decline year-over-year.
  • Terumo 2024 annual EPS was $0.49, a 12.05% increase from 2023.
  • Terumo 2023 annual EPS was $0.44, a 15.71% decline from 2022.
  • Terumo 2022 annual EPS was $0.52, a 8.75% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Terumo EPS - Earnings per Share 2012-2024 | TRUMY

  • Terumo EPS for the quarter ending June 30, 2024 was $0.15, a 13.1% decline year-over-year.
  • Terumo 2024 annual EPS was $0.49, a 12.05% increase from 2023.
  • Terumo 2023 annual EPS was $0.44, a 15.71% decline from 2022.
  • Terumo 2022 annual EPS was $0.52, a 8.75% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$204.2B
Stryker (SYK)$146.7B
Boston Scientific (BSX)$132.6B
EssilorLuxottica (ESLOY)$112.1B
Medtronic (MDT)$110.6B
Haleon (HLN)$43.7B
Lonza Group Ag (LZAGY)$42.2B
GE HealthCare Technologies (GEHC)$37.7B
ResMed (RMD)$35.8B
Koninklijke Philips (PHG)$24.8B
Zimmer Biomet Holdings (ZBH)$21.9B
Insulet (PODD)$18.4B
Baxter (BAX)$17B
Smith & Nephew SNATS (SNN)$11.1B
BellRing Brands (BRBR)$10.2B
Bio-Rad Laboratories (BIO)$9.3B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.3B
TG Therapeutics (TGTX)$5.5B
Haemonetics (HAE)$4.3B
Prestige Consumer Healthcare (PBH)$4.2B
ICU Medical (ICUI)$4.1B
Perrigo (PRGO)$3.8B
Envista Holdings (NVST)$3.7B
Neogen (NEOG)$3.2B
Agios Pharmaceuticals (AGIO)$3.2B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.8B
QuidelOrtho (QDEL)$2.7B
LeMaitre Vascular (LMAT)$2.4B